MMedXYNews
Ask AIHomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY News/Oncology

Section

Oncology

1,303 articles

Ask AI
All specialtiesOncologynewsClinical UpdatesCardiologyDiabetes & Endocrinology
Hematology-Oncology

Innovative CD20-Directed Autologous CAR T-Cell Therapy for Treatment-Refractory Waldenström Macroglobulinemia

This study demonstrates the promising safety and efficacy of CD20-targeted autologous CAR T-cell therapy in BTKi-refractory Waldenström macroglobulinemia, showing an 80% deep response rate and warranting further investigation in larger tria

MedXY Editorial Team
Nov 13, 2026

Latest updates

Oncology

Unveiling Microbial Signatures in Laryngeal Cancer: Targeting Parvimonas and Campylobacter for Novel Therapeutics

This study identifies distinct microbial dysbiosis in laryngeal cancer, highlighting Parvimonas and Campylobacter as potential therapeutic targets based on microbiome profiling of treatment-naive patients compared to controls.

Nov 13, 2026
Transplantation

Reevaluating Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: Comparable Outcomes to Hepatocellular Carcinoma in Selected Patients

Liver transplantation offers superior long-term survival compared to resection for combined hepatocellular-cholangiocarcinoma, with outcomes comparable to hepatocellular carcinoma when selecting patients without vascular invasion or poor di

Nov 13, 2026
Oncology

Global Proposal for the TNM Staging System for Poorly Differentiated Thyroid Cancer: A Paradigm Shift in Prognostic Stratification

This comprehensive review synthesizes emerging evidence supporting a new TNM staging system tailored for poorly differentiated thyroid cancer, demonstrating enhanced prognostic accuracy over existing differentiated thyroid cancer models.

Nov 13, 2026
Oncology

Personalized Impact of Pre-Radiotherapy Tooth Extraction on Osteoradionecrosis Risk in Head and Neck Cancer: Insights from Causal Machine Learning

This study uses causal machine learning to reveal that tooth extraction before radiotherapy neither universally reduces nor increases osteoradionecrosis risk, but individualized effects vary substantially, underscoring the need for patient-

Nov 13, 2026
Oncology

Ruzaltatug Rezetecan Versus Chemotherapy for EGFR-Mutated Advanced NSCLC Post-EGFR TKI Therapy: Interim Phase 3 HERON-Lung01 Analysis

Ruzaltatug rezetecan, a HER3-directed antibody-drug conjugate, significantly improves progression-free survival over chemotherapy with manageable safety in EGFR-mutated advanced NSCLC progressing after EGFR TKI therapy.

Nov 12, 2026
Oncology

Distinct Clinical Outcomes of Neoadjuvant PD-1 Inhibitors in Resectable Stage III Melanoma: Lymph Node Versus In-Transit Metastases

This population-based study reveals significant differences in pathological response and survival outcomes between stage III melanoma patients with lymph node metastases and those with in-transit metastases treated with neoadjuvant PD-1 inh

Nov 12, 2026
Oncology

Advancing Diversity in Oncology: Trends in Racial and Ethnic Representation Among Trainees from 2011 to 2025

This article examines significant improvements in underrepresented racial and ethnic minority representation among oncology trainees post-2020, highlighting progress and ongoing disparities in the oncology workforce.

Nov 12, 2026
Dermatology

Low-Dose Intralesional Cemiplimab Shows Promising Efficacy in Early-Stage Cutaneous Squamous Cell Carcinoma: Insights from a Phase 1 Dose-Escalation Study

A phase 1 study demonstrates that low-dose intralesional cemiplimab is safe and achieves high complete response rates in early-stage cutaneous squamous cell carcinoma, supporting further clinical exploration.

Nov 11, 2026
Plastic Surgery

Timing of Autologous Breast Reconstruction Post-Radiotherapy: Evaluating Safety and Outcomes

This article reviews a study on the impact of timing between postmastectomy radiotherapy and autologous breast reconstruction, highlighting no significant differences in complication rates across various intervals.

Nov 11, 2026
Otorhinolaryngology

Limitations of Preoperative Ultrasound in Predicting Papillary Thyroid Carcinoma Features: Clinical Implications for Surgical Planning

This study reveals that preoperative ultrasound frequently overestimates papillary thyroid carcinoma tumor size and has limited accuracy for detecting multifocality and extrathyroidal extension, suggesting caution in surgical decision-makin

Nov 11, 2026
Gastroenterology

VEGFA and EGF Genetic Variants: Impact on Cholangiocarcinoma Susceptibility and Postoperative Prognosis

VEGFA and EGF polymorphisms differentially affect cholangiocarcinoma susceptibility and postoperative survival, highlighting their potential as biomarkers for clinical stratification.

Nov 11, 2026
Gastroenterology

Neoadjuvant Immunotherapy in dMMR Colon Cancer: A Breakthrough in Survival Outcomes

The NICHE-2 trial demonstrates that neoadjuvant immunotherapy with ipilimumab and nivolumab yields 100% three-year disease-free and five-year overall survival in mismatch repair-deficient colon cancer patients, marking a potential new stand

Nov 9, 2026
Oncology

Decoding the Immune Landscape in NSCLC: Oncogene-Specific Spatial Proteomics Identifies Prognostic Niches and Therapeutic Targets

Spatial proteomics reveals how EGFR and KRAS mutations distinctly remodel the immune microenvironment in non-small cell lung cancer, identifying immune niches and prognostic markers that may guide immunotherapy strategies.

Nov 8, 2026
Oncology

Perioperative Durvalumab and Enfortumab Vedotin Regimens Enhance Outcomes in Muscle-Invasive Bladder Cancer

A pivotal phase 3 trial demonstrates improved event-free and overall survival with perioperative durvalumab combined with neoadjuvant enfortumab vedotin, with or without tremelimumab, versus surgery alone in muscle-invasive bladder cancer p

Nov 8, 2026
Oncology

FGFR Alterations in Bladder Cancer: From Molecular Pathogenesis to Precision Oncology

FGFR alterations, especially in FGFR3 and FGFR2, are pivotal biomarkers in urothelial carcinoma, advancing personalized diagnosis, treatment, and monitoring across disease stages. Emerging molecular diagnostics and targeted therapies promis

Nov 7, 2026
Oncology

Evaluating Sunitinib for Advanced and Metastatic Pheochromocytomas and Paragangliomas: Efficacy, Safety, and Clinical Implications from Prospective Trials

This meta-analysis synthesizes prospective data on sunitinib treatment in metastatic pheochromocytomas and paragangliomas, revealing modest response rates and meaningful disease control with manageable safety profiles.

Nov 6, 2026
Oncology

Evaluating Benmelstobart With or Without Anlotinib as Consolidation Therapy After Chemoradiotherapy in Unresectable Stage III NSCLC: Insights from the R-ALPS Trial

The R-ALPS randomized trial confirms that benmelstobart improves progression-free survival in unresectable stage III NSCLC patients post-chemoradiotherapy, while adding anlotinib does not significantly enhance efficacy and raises severe tox

Nov 6, 2026
Oncology

Izalontamab Brengitecan in Heavily Pretreated HR+/HER2- Breast Cancer: Insights from the PANKU-Breast01 Phase 3 Trial in China

This review details the phase 3 PANKU-Breast01 trial evaluating izalontamab brengitecan versus chemotherapy in pretreated HR+/HER2- breast cancer, highlighting significant PFS improvement and safety considerations in a Chinese cohort.

Nov 5, 2026
Gastroenterology

Evolving Patterns and Outcomes of Idiosyncratic Drug-Induced Liver Injury in the U.S.: Insights from the 20-Year DILIN Prospective Registry

Analysis of 1,983 high-certainty DILI cases over two decades reveals shifting drug causes, declining severity, increased herbal and oncology-related cases, and higher mortality among elderly, patients with chronic liver disease, and oncolog

Nov 5, 2026
1 / 25
123…25
Next

Most read

  1. 01General Surgery

    Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

  2. 02news

    Impact of Patient-Level Social Determinants on Colon Cancer Outcomes: A Novel Prognostic Measure Within an Integrated Health Network

  3. 03Hematology-Oncology

    Precision Immunotherapy in Acute Myeloid Leukemia: Advancing Beyond Traditional Targets

  4. 04General Surgery

    Maximizing Outcomes in Locally Advanced Pancreatic Cancer with Hypofractionated Ablative Radiation Therapy

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.